Monoclonal antibody (mAb) production methods (ascites, in vitro technologies, transgenic animals, and dicot or monocot transgenic plants; moss, algae) have been improved since they were first developed in 1975. In this study, we illustrate a summary of a study case in which mice, a hollow fiber system, and tobacco transgenic plants were assessed for the production of mAb for vaccine manufacturing and vaccine production.
| Autoren: |
|
Rodolfo Valdés, Andrés Tamayo, Marcos González, Sigifredo Padilla, Déborah Geada, William Ferro, Lorely Milá, Leonardo Gómez, Rosario Alemán, Alberto Leyva, Cristina García, Otto Mendoza, Tatiana Alvarez, Lamay Dorta, Yanet Villega, Dobián Cecilia, Hasel Aragón, Tatiana González, Maylín La O, Jorge López |
| Journal: |
|
Biotechnology and Bioprocess Engineering
|
| Jahrgang: |
|
2012 |
| DOI: |
|
10.1007/s12257-011-0196-2 |
| Erscheinungsdatum: |
|
02.02.2012 |